Identifying the molecular mechanisms by which malignant cells derail anti-tumor immune responses to instead favor immune programs that facilitate tumor progression to metastasis. Understanding the immune microenvironment in which tumor cells reside will allow for the identification of pharmacological targets that can be exploited to destroy malignant disease.
- 2005: PhD, molecular cell biology, Baylor College of Medicine, Houston
- 2006 - 2010: Postdoctoral fellow, cancer immunology, University of California, San Francisco
Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.